The 8th annual Gut Microbiota for Health (GMFH) World Summit was held on March 23 &
24, 2019, in Miami, Florida. Organized jointly by AGA and the European Society of
Neurogastroenterology and Motility (ESNM), the GMFH World Summit is the preeminent meeting on the
gut microbiota. These on-demand recordings provide a "best of" look at the 2019 sessions, which
focused on the interaction between diet, nutrition and the gut microbiome.
Sign in to
access
After you sign in, please click the "Launch" button on the top of this page to access the quiz.
Product features:
- Current Understanding of the Human Microbiome - Jack A. Gilbert, PhD, University of California,
San Diego
- FODMAPs and IBS - Magnus Simrén, MD, PhD, University of Gothenburg (Sweden)
- Microbiome Dynamics in Metabolic Diseases - Christoph Thaiss, PhD, University of Pennsylvania
- Low Dietary Fiber-Induced Mucosal Erosion Worsens Spontaneous Colitis in Genetically Susceptible
Hosts - Eric Martens, PhD, University of Michigan
- Dietary Fiber and Foundation Guild of Healthy Gut Microbiota - Liping Zhao, PhD, Rutgers, The
State University of New Jersey
- Exercise, Fitness, Diet and the Gut Microbiome - Paul Cotter, PhD, University College Cork
(Ireland)
- Microbe-Derived Metabolites and the Liver - Rohit Loomba, MD, University of California, San
Diego
Course directors and faculty:
Gail Hecht, MD, MS, AGAF (co-chair)
Francisco Guarner, MD, PhD (co-chair)
Giovanni Barbara, MD
Joël Doré, PhD
Dirk Haller, PhD
Purna Kashyap, MBBS
Colleen Kelly, MD
Emeran Mayer, MD
D. Brent Polk, MD, AGAF
R. Balfour Sartor, MD
Robert Schwabe, MD
Hania Szajewska, MD
Michael Trauner, MD, AGAF
Gary D. Wu, MD, AGAF
Learning objectives
- Understand the role of diet-microbiota interactions underlying human health and disease.
- Describe current evidence regarding dietary components (such as dietary fiber and fermented
foods) and exercise and their influence on the human gut microbiome.
- Describe current understanding of metabolites produced by the gut microbiome and their link to
human health and disease.
- Apply current understanding of probiotics for the management of adult and pediatric
gastrointestinal disorders to clinical practice.
Pricing
Member |
Nonmember |
Free |
Free |
Sign in to access
Faculty relationship and financial disclosures
Dr. Cotter has reported no financial relationships with a commercial interest.
Dr. Gilbert has disclosed the following financial relationships with a commercial interest:
- Stock Shareholder: BiomeSense
- Advisory Committee/Review Panel: DayTwo, Holobiome
Dr. Loomba has disclosed the following financial relationships with a commercial interest:
- Consultant or Advisory Board Member: Arrowhead Pharmaceuticals, AstraZeneca, Bird Rock Bio,
Boehringer Ingelheim, Bristol-Myer Squibb, Celgene, Cirius, CohBar, Conatus, Eli Lilly, Galmed,
Gemphire, Gilead, Glympse bio, GNI, GRI Bio, Intercept, Ionis, Janssen Inc., Merck, Metacrine,
Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Pfizer, Prometheus, Sanofi, Siemens,
Viking Therapeutics.
- Grant/Research Support: Allergan, Boehringer-Ingelheim, Bristol-Myers Squibb, Cirius, Eli Lilly
and Company, Galectin Therapeutics, Galmed Pharmaceuticals, GE, Genfit, Gilead, Intercept,
Janssen, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, NuSirt, Pfizer, Prometheus,
Siemens.
- Co-founder of Liponexus, Inc.
Dr. Martens has disclosed the following financial relationships with a commercial interest:
- Consultant: January Inc, Kaleido Biosciences
Dr. Simren has disclosed the following financial relationships with a commercial interest:
- Consultant or Advisory Board Member: AstraZeneca, Danone Nutricia Research, Nestlé, Almirall,
Allergan, Albireo, Glycom, Shire
- Grant/Research Support: Danone Nutricia Research, Ferring Pharmaceuticals
- Speaker: Tillotts, Menarini, Biocodex, Alfasigma, Takeda, Shire, Allergan, Almirall
Dr. Thaiss has reported no financial relationships with a commercial interest.
Dr. Zhao has reported no financial relationships with a commercial interest.
Commercial supporters
Danone (GMFH Founding Supporter)
Sanofi (Sustaining Supporter)
Bio-K Plus International Inc.
Rebiotix Inc, part of the Ferring Pharmaceuticals Group
Seres Therapeutics